We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Blog

Developing Neuroprotective Therapies: Defending the Nervous System from Damage

Developing Neuroprotective Therapies: Defending the Nervous System from Damage

Blog

the University of Texas MD Anderson Cancer Center and Accelerator Life Science Partners recently announced the launch of Magnolia Neurosciences Corporation – a biopharmaceutical company advancing a new class of neuroprotective medicines.

Read More

Single Cell Analysis with the BD AbSeq Assay

Single Cell Analysis with the BD AbSeq Assay

Blog

New tools are enabling researchers to explore individual cells with unprecedented clarity, allowing RNA and protein expression levels to be simultaneously analyzed. In this blog, Brian Lilhanand, Global Platform Leader, Single Cell Multiomics, at BD, discusses how BD’s new AbSeq Assay can provide this targeted profiling and benefit immunology researchers.





Read More

Moving Past Paper: Realizing the Potential of ELNs

Moving Past Paper: Realizing the Potential of ELNs

Blog

Electronic Laboratory Notebooks are becoming more popular as labs embrace digitization. ELN provider Biodata’s flagship offering, Labguru, has over 30,000 users worldwide. We caught up with Steve Yemm, recently appointed CEO of BioData, to ask him about the advantages of ELNs and the challenges they face in a digital market.

Read More

Why is China Becoming a Microfluidics Manufacturing Superpower?

Why is China Becoming a Microfluidics Manufacturing Superpower?

Blog

Many Chinese microfluidics companies are emerging and expanding, and it could be game-changing for the industry. We spoke with Yole Développement analyst, Sébastien Clerc, to learn more.

Read More

Helping Rare Disease Reseach BeHEARD

Helping Rare Disease Reseach BeHEARD

Blog

Earlier this summer, the Rare Genomics Institute announced the winners of the 2018 BeHEARD (Help Empower & Accelerate Research Discoveries) Challenge. The Challenge tasks researchers or foundations working in fields of rare disease research to apply for grants, either financial or technological, to assist their research. We caught up with the Institute’s Arvin M. Gouw to discuss the awards and the battle against rare disease.

Read More

Injectable Discogenic Cell Therapy Developed to Alleviate Back Pain

Say Hello to Regenerative Medicine and Goodbye to Back Pain

Blog

Degenerative disc diseases are debilitating, and treatment options are lacking. Three leaders from Discgenics explain how they are harnessing the restorative potential of cells native to the intervertebral disc to alleviate lower back pain.

Read More

Tackling Antibiotic-resistance: Nitric Oxide-based Treatments for Respiratory Diseases

Tackling Antibiotic-resistance: Nitric Oxide-based Treatments for Respiratory Diseases

Blog

The failure of conventional antibiotics to treat numerous antibiotic-resistant infections necessitates the development of new agents – as a natural anti-microbial nitric oxide holds particular promise.

Read More

In Vitro Systems and Inhalation Toxicology

In Vitro Systems and Inhalation Toxicology

Blog

In early July, experts from around the world met in Nice, France, to share and discuss the latest innovations and research in the context of human lung in vitro models. This blog highlights some of the topics covered during the event.

Read More

Going with the Flow

Going with the Flow

Blog

This month we sat down with Dr Omar Jina, Chief Commercial Officer at Syrris Ltd., to discuss flow chemistry, its applications and the push to raise awareness of this transformative technology.

Read More

Treating Diseases Associated with Pathogenic Proteins Expressed by Human Endogenous Retroviruses

Treating Diseases Associated with Pathogenic Proteins Expressed by Human Endogenous Retroviruses

Blog

We recently spoke to Dr. Hervé Perron, HDR, Chief Scientific Officer at GeNeuro to learn about their progress developing new treatments for neurological and autoimmune diseases associated with pathogenic proteins expressed by human endogenous retroviruses (HERVs).

Read More